Considering they haven't even filed an IND yet I don't know how they're going to get it going until mid-2011.
(which is one reason I have been saying ARIA use a larger partner or sell the company). Ariad doesn't have the financial resources to do all these things they need to do. $75 million in cash is nowhere near enough money to do a CML, AML, solid tumor trials in 534, and launch human studies in ALK.
Ariad = snails pace because they have a greedy CEO
Market Data 
Markets 
AI
